Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Revenue
$2.59B
TTM · Period ending: · USD
BIO Revenue
Latest reported$2.59Bperiod ending
Latest reported$2.59Bperiod ending
BIO Revenue ($102.30M → $2.59B)
Annual revenue
High-resolution chart · PNG
BIO revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue (USD) |
|---|---|
| 2,583,200,000 | |
| 2,566,500,000 | |
| 2,671,262,000 | |
| 2,802,249,000 | |
| 2,922,545,000 | |
| 2,545,626,000 | |
| 2,311,659,000 | |
| 2,290,109,000 | |
| 2,160,153,000 | |
| 2,068,172,000 | |
| 2,019,441,000 | |
| 2,175,044,000 | |
| 2,132,694,000 | |
| 2,069,235,000 | |
| 2,073,529,000 | |
| 1,927,118,000 | |
| 1,784,244,000 | |
| 1,764,365,000 | |
| 1,461,052,000 | |
| 1,273,930,000 | |
| 1,180,985,000 | |
| 1,090,012,000 | |
| 1,003,382,000 | |
| 892,720,000 | |
| 817,509,000 | |
| 725,884,000 | |
| 549,500,000 | |
| 441,900,000 | |
| 426,900,000 | |
| 418,800,000 | |
| 396,600,000 | |
| 355,300,000 | |
| 328,600,000 | |
| 330,300,000 | |
| 310,700,000 | |
| 286,700,000 | |
| 236,300,000 | |
| 198,900,000 | |
| 159,500,000 | |
| 126,600,000 | |
| 102,300,000 |